Pressroom

fiercebiotechReport Cards Could be Just What Pharma Needs to get Back to Respectability
FierceBiotech, Feb. 1, 2017
In 1997, 79% of people in the U.S. believed pharma companies were honest and ethical. Today that percentage has plummeted to just 10%. But one researcher has an idea about how to reverse the slide…

BioSpace Good Pharma Scorecard: Pharma’s Worst Fear or Newest Ally?
BioSpace.com, Steve Zisson, September 26, 2016
It’s time for pharmaceutical companies to start trusting someone on transparency and maybe Bioethics International is as good a place as any to start. Bioethics International is set to release the second iteration of its Good Pharma Scorecard that ranks life science companies on clinical trials transparency. Biotech and pharma companies should brace themselves for more bad news even though some companies already got early looks at the results. The negative news is something companies should be used to by now and it is time to get past it….


MedCity Faster registration, more transparency punctuate new HHS clinical trial final rule
MedCity News, Josh Baxt, September 22, 2016
The Department of Health and Human Services (HHS) issued its final rule on submitting registration and summary results to clinicaltrials.gov. In a nutshell, the new guidelines define which clinical trials must be registered and when, how results should be reported (and when) and potential enalties for non-compliance….


Forbes interviews Bioethics International’s Founder on the Good Pharma Scorecard
brandforbes.com, August 17, 2016
Today several pharmaceutical companies are set to meet with New York University assistant professor Jennifer Miller to find out how they scored on her soon-to-be released Good Pharma Scorecard—a comprehensive ranking that will show how effective they are at communicating results from clinical trials that lead up their drugs getting approved by the FDA….


How Much do we Know about New Drugs?  NPR interviews Jennifer Miller on the Good Pharma Scorecard
biotechnation.podomatic.com, August 1, 2016

460>_11207060NPR’s Dr. Moira Gunn and Dr. Jennifer Miller, Founder and President of Bioethics International and a professor at NYU Medical School, talk about the Good Pharma Scorecard.


In Clinical Trials, For-profit Review Boards Are Taking Over For Hospitals. Should They?
statnews.com, July 6, 2016

cropped-stat-logo-tealFor years, ethicists warned medical researchers that paying businesses to evaluate their clinical trials was a bad idea…


Biden Threatens Funding Cuts For Researchers Who Fail To Report Clinical Trial Results
statnews.com, June 29, 2016

cropped-stat-logo-tealAt a national cancer summit Wednesday, Vice President Joe Biden threatened to cut funds to medical research institutions that don’t report their clinical trial results in a timely manner…


Creating Benchmarks For Ethical Pharma (PDF)
thepharmaletter.com,
June 29, 2016

tplJennifer Miller is the founding president of Bioethics International (BEI), a US-based non-profit organization…


Laura and John Arnold Foundation Announces $3.6 Million Grant To Increase Clinical Trial Transparency For FDA Approved Drugs and Interventions.
arnoldfoundation.org, May 17, 2016

ljafThe Laura and John Arnold Foundation (LJAF) announced a $3.6 million grant to Bioethics International. The funding will allow the nonprofit group to…


Bioethics International’s Good Pharma Scorecard Publication Selected as BMJ Open Editors’ Pick for 2015
prnewswire.com, Feb. 11, 2016

PRNEWSBioethics International, a not-for-profit organization focused on the ethics and governance of how medicines are researched, developed, marketed and made accessible to patients…


Non-profit Works to Keep Tabs on Big Pharma
ny1.com, Monday, January 25, 2016

NY1-video-012516The pharmaceutical industry is consistently ranked as one of the least liked industries in the country, with many Americans questioning the ethics of big pharma companies. One non-profit group hopes to bring some much needed accountability to the sector…


French Debacle Renews Concern About Clinical Trial Secrecy
statnews.com, Jan. 20, 2015

The death of a French volunteer in a clinical trial renewed concerns about the lack of public reporting of results of such early-stage human studies…


Podcast: A Scorecard to Improve Drugmakers’ Transparency

The Bio Report, Nov. 25, 2015


How Pharma Keeps a Trove of Drug Trials Out of Public View
The Washington Post, Nov. 12, 2015

washpostA third of the clinical trial results that federal regulators reviewed to approve drugs made by large pharmaceutical companies in 2012 were never publicly reported, according to a new study that grades companies on their transparency….


Drugmakers Kept One-Third of Trial Results Secret, Study Finds
Bloomberg News, Nov. 12, 2015

bloombergPharmaceutical companies including Gilead Sciences Inc. and Sanofi kept secret more than a third of all clinical trial results for 15 drugs approved in 2012, according to a study…


Study Finds Big Pharma Skirts Laws, Ethical Standards in Keeping Trial Data Secret
Boston Business Journal, Nov. 12, 2015

bostonEight years after a federal law required most drug trials to be made public, fully one third of all trial results from a sampling of drugs developed by big pharma and approved in 2012 remain a secret from almost everyone, according to a study published today….

 


Biopharmas (Mostly) Meet Mandatory Trial Reporting But Fall Flat Voluntarily
BioWorld Today, Nov. 12, 2015

bioworldThe decade-old drumbeat for clinical trials transparency grew louder with release of a paper in BMJ Open about the dearth of voluntary data reporting – sometimes even from late-stage trials – on drugs that were subsequently approved…..


BMJ Publishes ‘Transparency Scorecard’
BioCentury, Nov. 12, 2015

biocenturyIn a study published Thursday in The BMJ, researchers from not-for-profit organization Bioethics International and colleagues concluded that disclosures of trial data for new drugs “remain below legal and ethics standards.” The authors…


medcityGilead, Sanofi Would Tank in Bioethics International’s New Good Pharma Scorecard
MedCity News, Nov. 12, 2015

Today, we celebrate the advent of a “Good Pharma Scorecard” from New York-based nonprofit Bioethics International – and for good reason…


fiercebiotechUPDATED: Gilead, Sanofi Singled Out As Worst Offenders In Failing To Disclose Trial Data
FierceBiotech, Nov. 12, 2015

When it comes to publishing a full set of trial data on new drugs, the biopharma industry overall has a poor record on transparency, according to a new report from a bioethics watchdog group…


Pharmaceutical Scorecard Shames Giants Over Research Cover-ups
The Australian, Nov. 12, 2015

Scientists have created a new league table to shame pharmaceutical giants into disclosing the results of clinical trials. The “Good Pharma Scorecard”, published overnight in the journal BMJ Open, ranks biomedical corporations on their transparency when they introduce new drugs.


New Report Shows Evidence of Poor Clinical Trial Data Disclosure In FDA Applications
The Pharma Letter, Nov. 12, 2015


Study Finds Big Pharma Inconsistent With Disclosure of Clinical Trial Data
European Pharmaceutical Review, Nov. 12, 2015


Drug Firms Far From Transparent With Trial Data Watchdog Group Finds
Seeking Alpha, Nov. 12, 2015


Five Things For Pharma Marketers To Know
Medical Marketing & Media, Nov. 12, 2015


Will New Rules to Toughen Reporting of Trial Results Make a Difference?
Wall Street Journal, Dec. 5, 2014


Push for Data Disclosure
The Scientist, Nov. 21, 2014


US Government Cracks Down on Clinical Trials Reporting
Nature, Nov. 19, 2014


New Ethics Fellow to Research Transparency in Health Care
Duke Chronicle, Sept. 29, 2014


Moira Gunn Interviews Dr. Jennifer Miller on the Ethics of Clinical Trial
NPR’s BioTechNation, Aug. 31, 2014
(podcast, start at minute 35)


Ice Bucket Challenge Nets Millions for ALS Charity
CBS, Aug. 18, 2014


Rating Companies’ Global Health Footprint
Harvard University, Dec. 9, 2013
(video, start at minute 18)


BEI’s Ethics Panel for BIO’s International Convention 
BioProcess International, March 2010


Bioethicist’s Work Bridges Science, Law, and Religion
Science, June 5, 2009


 

Press and Media Inquires

All press and media inquiries should be directed to:
Jennifer Miller, Founder
Bioethics International
jmiller@bioethicsinternational.org

 

Save

Save

Save

Save

Save

Save